When Anita Michael walks into a facility to help facilitate a US FDA inspection of a combination drug-device product-maker, one of the first things she and agency investigators must determine is whether the firm's quality system is drug- or device-led.
"We would want to know, what is your main system? Do you have a CGMP [Current Good Manufacturing Practice]...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?